Compass Therapeutics Files 8-K on Shareholder Vote Matters
Ticker: CMPX · Form: 8-K · Filed: Jun 12, 2025 · CIK: 1738021
| Field | Detail |
|---|---|
| Company | Compass Therapeutics, Inc. (CMPX) |
| Form Type | 8-K |
| Filed Date | Jun 12, 2025 |
| Risk Level | low |
| Sentiment | neutral |
Sentiment: neutral
Topics: shareholder-vote, corporate-governance
TL;DR
Compass Therapeutics held a shareholder vote on June 11th, details filed today.
AI Summary
Compass Therapeutics, Inc. filed an 8-K on June 12, 2025, reporting on matters submitted to a vote of security holders on June 11, 2025. The filing details the company's corporate actions and governance, as is standard for this type of report.
Why It Matters
This filing indicates that Compass Therapeutics held a shareholder vote, which could pertain to significant corporate decisions like board elections or major strategic changes.
Risk Assessment
Risk Level: low — This is a routine 8-K filing regarding a shareholder vote, not indicating any immediate financial distress or significant operational change.
Key Players & Entities
- Compass Therapeutics, Inc. (company) — Registrant
- June 11, 2025 (date) — Date of earliest event reported
- June 12, 2025 (date) — Date of report
- Delaware (jurisdiction) — State of Incorporation
- 80 Guest Street, Suite 601, Boston, Massachusetts 02135 (address) — Principal Executive Offices
FAQ
What specific matters were submitted to a vote of Compass Therapeutics' security holders on June 11, 2025?
The filing does not specify the exact matters voted upon, only that "Submission of Matters to a Vote of Security Holders" was the item of information.
When was the Form 8-K filed with the SEC?
The Form 8-K was filed on June 12, 2025.
What is the principal executive office address for Compass Therapeutics?
The principal executive offices are located at 80 Guest Street, Suite 601, Boston, Massachusetts 02135.
What is Compass Therapeutics' telephone number?
The registrant's telephone number is (617) 500-8099.
What is the SIC code for Compass Therapeutics?
The Standard Industrial Classification (SIC) code for Compass Therapeutics is 2836, for Biological Products (No Diagnostic Substances).
Filing Details
This Form 8-K (Form 8-K) was filed with the SEC on June 12, 2025 regarding Compass Therapeutics, Inc. (CMPX).